Zhitong Finance App News, Yifan Pharmaceutical (002019.SZ) issued an announcement. On November 4, 2026, Hefei Yifan Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Acceptance” issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) for registration and marketing of vinblastine sulfate injection domestically produced drugs.

Zhitongcaijing · 4d ago
Zhitong Finance App News, Yifan Pharmaceutical (002019.SZ) issued an announcement. On November 4, 2026, Hefei Yifan Biopharmaceutical Co., Ltd., a wholly-owned subsidiary of the company, received the “Notice of Acceptance” issued by the China Drug Administration (hereinafter referred to as the “State Drug Administration”) for registration and marketing of vinblastine sulfate injection domestically produced drugs.